New Study Reviews Therapeutic Candidates for Measles
A new peer-reviewed study co-authored by IMA President Dr. Joseph Varon and Director of Research Matthew Halma adds to a growing body of research aimed at exploring therapeutic candidates for measles. Published in Antiviral Research, this systematic review compiles clinical evidence for treatment options—the kind of information that could help patients and physicians make informed decisions. So why isn’t it part of the conversation?
Please have a read here, and then download the paper. It’s free to download, (I think,) for 40 days.
Really getting tired of the fear button being hit again and again, and so many thoughtlessly panicking. Maybe I’m wrong, but it just happens so often. Every time the IMA and colleague publish papers like this, I feel that we’re helping turn this crazy ‘medical disinformation’ ship in a much more honest direction.